HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 217-228 of 4,505
Behavioral study icon
Enrolling By InvitationNCT07173192

The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients

Official study title

The Effect of an Individual Empowerment Program Applied to Primary Caregivers of Patients Diagnosed With Schizophrenia on the Burden of Care, Psychological Well-being, and Self-efficacy: A Randomized Controlled Experimental Study

This study is by invitation only.

In Istanbul
SchizophreniaBehavioural studyAges 18–65
Countries
Türkiye
Sponsor
Istanbul Arel University
Other study type icon
Not Yet RecruitingACTRN12607000199415

The Cardiac Complications Of Clozapine Study

Official study title

Identifying Early Subtle Changes In Cardiac Function That Precede Overt Dysfunction In Schizophrenic Patients Taking Clozapine

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaObservational studyAges 18+
Countries
Sponsor
Department of Cardiology, Eastern Health
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Multiple locations, including Orange
SchizophreniaMedication studyAges 55–90
Countries
United States, France, United Kingdom, + 10 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Multiple locations, including Stuart
SchizophreniaMedication studyAges 55–90
Countries
United States, Canada, United Kingdom, + 11 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

Official study title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis

Multiple locations, including Phoenix
SchizophreniaMedication studyAges 55–90
Countries
United States, France, Canada, + 12 others
Sponsor
MapLight Therapeutics
Behavioral study icon
RecruitingNCT05617898

Determining the Role of Social Reward Learning in Social Anhedonia

Official study title

Determining the Role of Social Reward Learning in Social Anhedonia in First-Episode Psychosis Using Motivational Interviewing in a Perturbation-Based Neuroimaging Approach

Multiple locations, including Birmingham
SchizophreniaBehavioural studyAges 18–35
Countries
United States
Sponsor
University of Alabama at Birmingham
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.